Antitumor activities with a recombinant endoglin-MIP3a/Fc fusion protein as a model antigen

被引：0
|
作者：
He, Z. [1 ]
Liu, S. [1 ]
Lu, Y. [1 ]
Huang, Y. [1 ]
Guo, J. [1 ]
Zheng, S. [1 ]
机构：
[1] Hainan Med Univ, Affiliated Hosp 1, Tumor Inst, Haikou, Hainan, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1671
引用
收藏
页码：1675 / 1676
页数：2
相关论文
共 50 条
  • [1] Antitumor activities of recombinant FGFR1-PD1-MIP3a/Fc fusion protein vaccine in mice model
    Zhang, X.
    Tian, S.
    Huang, Y.
    Liu, S.
    Zheng, L.
    Zheng, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1775 - 1775
  • [2] Anti-tumor activity of a recombinant endoglin-MIP3α Fc-fusion protein in mice with hepatocellular carcinoma
    He, Zhi-hui
    Liu, Si-ru
    Wu, Xin-lai
    Huang, Yong-hao
    Chen, Yan
    Deng, Yi
    Xie, Pan-pan
    Lu, Yan-da
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2019, 12 (14) : 54 - 58
  • [3] Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen
    Tan, GH
    Wei, YQ
    Tian, L
    Zhao, X
    Yang, L
    Li, J
    He, QM
    Wu, Y
    Wen, YJ
    Yi, T
    Ding, ZY
    Kan, B
    Mao, YQ
    Deng, HX
    Li, HL
    Zhou, CH
    Fu, CH
    Xiao, F
    Zhang, XW
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (07) : 2012 - 2021
  • [4] Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
    Powell, Jerry S.
    Pasi, K. John
    Ragni, Margaret V.
    Ozelo, Margareth C.
    Valentino, Leonard A.
    Mahlangu, Johnny N.
    Josephson, Neil C.
    Perry, David
    Manco-Johnson, Marilyn J.
    Apte, Shashikant
    Baker, Ross I.
    Chan, Godfrey C.
    Novitzky, Nicolas
    Wong, Raymond S.
    Krassova, Snejana
    Allen, Geoffrey
    Jiang, Haiyan
    Innes, Alison
    Li, Shuanglian
    Cristiano, Lynda M.
    Goyal, Jaya
    Sommer, Jurg M.
    Dumont, Jennifer A.
    Nugent, Karen
    Vigliani, Gloria
    Brennan, Aoife
    Luk, Alvin
    Pierce, Glenn F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24): : 2313 - 2323
  • [5] Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A
    Mahlangu, Johnny
    Powell, Jerry S.
    Ragni, Margaret V.
    Chowdary, Pratima
    Josephson, Neil C.
    Pabinger, Ingrid
    Hanabusa, Hideji
    Gupta, Naresh
    Kulkarni, Roshni
    Fogarty, Patrick
    Perry, David
    Shapiro, Amy
    Pasi, K. John
    Apte, Shashikant
    Nestorov, Ivan
    Jiang, Haiyan
    Li, Shuanglian
    Neelakantan, Srividya
    Cristiano, Lynda M.
    Goyal, Jaya
    Sommer, Jurg M.
    Dumont, Jennifer A.
    Dodd, Nigel
    Nugent, Karen
    Vigliani, Gloria
    Luk, Alvin
    Brennan, Aoife
    Pierce, Glenn F.
    BLOOD, 2014, 123 (03) : 317 - 325
  • [6] Population Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein
    Nestorov, Ivan
    Neelakantan, Srividya
    Ludden, Thomas M.
    Li, Shuanglian
    Jiang, Haiyan
    Rogge, Mark
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (03): : 163 - 174
  • [7] Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities
    Tan, GH
    Tian, L
    Wei, YQ
    Zhao, X
    Li, J
    Wu, Y
    Wen, YJ
    Yi, T
    Ding, ZY
    Kan, B
    Mao, YQ
    Deng, HX
    Li, HL
    Zou, CH
    Fu, CH
    INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (04) : 701 - 706
  • [8] Recombinant Fusion Factor VIII-Fc Fusion Protein in Severe Haemophilia A Patients
    Le Quellec, Sandra
    HEMATOLOGIE, 2014, 20 (06): : 304 - 306
  • [9] Evidence For Flexible Tethering Of Fc To FVIII In Recombinant FVIII-Fc Fusion Protein rFVIIIFc
    Leksa, Nina
    Liu, Lucy
    Goodman, Allison
    Chiu, Po-lin
    Walz, Thomas
    Peters, Robert
    Kulman, John
    BLOOD, 2013, 122 (21)
  • [10] POPULATION PHARMACOKINETIC MODEL FOR RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC) VALIDATED AND OPTIMIZED FOR USE IN CHILDREN
    Bukkems, L. H.
    Heijdra, J. M.
    Mathias, M.
    Collins, P. W.
    Hay, C. R. M.
    Leebeek, F. W. G.
    Meijer, K.
    Fijnvandraat, K.
    Chowdary, P.
    Cnossen, M. H.
    Mathot, R. A. A.
    HAEMATOLOGICA, 2019, 104 : 14 - 14
12345